Stock YTEN YIELD10 BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Yield10 Bioscience, Inc.

Equities

YTEN

US98585K8624

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.2345 USD -8.75% Intraday chart for Yield10 Bioscience, Inc. -15.80% -2.01%
Apr. 01 Transcript : Yield10 Bioscience, Inc., Q4 2023 Earnings Call, Apr 01, 2024
Apr. 01 Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Yield10 Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Yield10 Bioscience, Inc. Announces the Plant Biosafety Office of the Canadian Food Inspection Agency Clear Genome-edited E3902 Camelina for Planting in Canada
Top Midday Gainers
Yield10 Bioscience, Inc. Grants Global License to VISION Bioenergy Oilseeds, LLC for Herbicide Tolerant Camelina Cultivated for Production of Biofuel Feedstock
Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected
US Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade Data
Yield10 Bioscience, Inc. Provides an Update on Its Omega-3 Camelina Program
Yield10 Bioscience, Inc. Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil
Yield10 Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Yield10 Bioscience, Inc. Contemplates Bankruptcy.
Yield10 Bioscience, Inc. and Biomar Group Aim to Grow Fish Oil on Land
Yield10 Bioscience, Inc. Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Production Technology from Rothamsted Research
Sector Update: Health Care Stocks Softer Late Afternoon
Sector Update: Health Care
Yield10 Bioscience Acquires License to Commercialize Advanced Omega-3 Technology
Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research
Yield10 Bioscience, Inc. Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina
Yield10 Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Top Midday Decliners
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. YTEN Stock
  4. News Yield10 Bioscience, Inc.
  5. Other languages